Clinical trial
Evaluation of the CooperVision, Inc. Sapphire and Pearl Silicone Hydrogel Daily Wear Contact Lenses When Used for Frequent Replacement for Up to One (1) Month of Daily Wear.
NCT02362724 is registered in ClinicalTrials.gov with CooperVision, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the CooperVision, Inc. Sapphire and Pearl Silicone Hydrogel Daily Wear Contact Lenses When Used for Frequent Replacement for Up to One (1) Month of Daily Wear.
- Lead sponsor
- CooperVision, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- December 31, 2015
- Enrollment
- 89 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
ametropia